MDLinx6 Supplements with Surprising but Severe Health Risks

Three-quarters of Americans take supplements, yet six common options trigger severe reactions including liver failure, serotonin syndrome, and cardiac events. FDA banned ephedra in 2004, but kratom, CBD, and St. John’s wort remain unregulated despite documented organ damage and dangerous drug interactions.

⚖️ PROFESSIONAL IMPACT

• Kratom causes liver injury, seizures, and neuropsychiatric effects in patients with psychiatric illness or substance use history, yet remains legally available for self-medication.
• CBD elevates liver enzymes and interacts with anti-epileptic drugs, antidepressants, and opioid analgesics that psychiatric patients commonly take.
• St. John’s wort triggers serotonin syndrome when combined with antidepressants and accelerates liver enzyme breakdown of contraceptives, anticoagulants, and immunosuppressants.
• High-dose biotin interferes with troponin assays, causing false-negative cardiac tests and delayed MI diagnosis in emergency settings.

🎯 ACTION ITEMS

• Screen all psychiatric patients for supplement use at intake and medication changes.
• Document specific contraindications for St. John’s wort with SSRIs, SNRIs, and MAOIs.
• Warn patients that kratom dependence and withdrawal mirror opioid patterns.
• Advise stopping biotin 72 hours before cardiac biomarker testing or emergency evaluation.

More on Drug Safety & Interactions